Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:40:48.184Z.
Calculation as of: 2026-10-06T15:40:48.184Z.
Quote observation: 2026-10-06T15:40:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9f7ef7d03019e78f4201474ef0c74f9c2a497de6c29d743f28e52983e243880
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.10B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.09B
Price/FCF Ratio
79.05
TTM Avg
106.42
3Y Avg
106.42
5Y Avg
106.42
Market Cap
$3.14B
Price/FCF Ratio
N/A
TTM Avg
16.27
3Y Avg
21.05
5Y Avg
21.05
Market Cap
$2.82B
Price/FCF Ratio
35.68
TTM Avg
52.84
3Y Avg
87.29
5Y Avg
87.29
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.10B | N/A | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.10B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 79.05 | 106.42 | 106.42 | 106.42 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.14B | N/A | 16.27 | 21.05 | 21.05 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.82B | 35.68 | 52.84 | 87.29 | 87.29 |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 54.29 | 72.35 | 93.08 | 93.08 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.41B | N/A | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.43B | 40.34 | 30.07 | 190.37 | 190.37 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2024-08-08 | 7.91 |
| 2024-08-07 | 8.26 |
| 2024-08-06 | 8.66 |
| 2024-08-05 | 8.66 |
| 2024-08-02 | 8.88 |
| 2024-08-01 | 9.09 |
| 2024-07-31 | 9.05 |
| 2024-07-30 | 8.39 |
| 2024-07-29 | 8.52 |
| 2024-07-26 | 8.66 |
| 2024-07-25 | 8.44 |
| 2024-07-24 | 8.44 |
| 2024-07-23 | 8.61 |
| 2024-07-22 | 8.70 |
| 2024-07-19 | 8.88 |
| 2024-07-18 | 8.79 |
| 2024-07-17 | 9.31 |
| 2024-07-16 | 10.37 |
| 2024-07-15 | 9.49 |
| 2024-07-12 | 9.49 |
| 2024-07-11 | 10.02 |
| 2024-07-10 | 9.09 |
| 2024-07-09 | 7.25 |
| 2024-07-08 | 7.25 |
| 2024-07-05 | 7.56 |
| 2024-07-03 | 7.78 |
| 2024-07-02 | 7.64 |
| 2024-07-01 | 8.26 |
| 2024-06-28 | 8.35 |
| 2024-06-27 | 8.48 |
| 2024-06-26 | 8.04 |
| 2024-06-25 | 8.13 |
| 2024-06-24 | 8.04 |
| 2024-06-21 | 7.82 |
| 2024-06-20 | 7.25 |
| 2024-06-18 | 7.12 |
| 2024-06-17 | 7.25 |
| 2024-06-14 | 7.21 |
| 2024-06-13 | 7.38 |
| 2024-06-12 | 7.51 |
| 2024-06-11 | 7.64 |
| 2024-06-10 | 7.73 |
| 2024-06-07 | 7.78 |
| 2024-06-06 | 7.73 |
| 2024-06-05 | 7.73 |
| 2024-06-04 | 7.51 |
| 2024-06-03 | 7.47 |
| 2024-05-31 | 7.56 |
| 2024-05-30 | 7.38 |
| 2024-05-29 | 7.34 |
| 2024-05-28 | 7.51 |
| 2024-05-24 | 7.60 |
| 2024-05-23 | 7.82 |
| 2024-05-22 | 8.04 |
| 2024-05-21 | 7.91 |
| 2024-05-20 | 8.08 |
| 2024-05-17 | 8.04 |
| 2024-05-16 | 8.04 |
| 2024-05-15 | 8.00 |
| 2024-05-14 | 8.22 |
| 2024-05-13 | 8.00 |
| 2024-05-10 | 7.73 |
| 2024-05-09 | 12.25 |
| 2024-05-08 | 12.51 |
| 2024-05-07 | 12.77 |
| 2024-05-06 | 12.90 |
| 2024-05-03 | 13.15 |
| 2024-05-02 | 12.96 |
| 2024-05-01 | 12.51 |
| 2024-04-30 | 11.73 |
| 2024-04-29 | 12.31 |
| 2024-04-26 | 11.41 |
| 2024-04-25 | 11.53 |
| 2024-04-24 | 12.18 |
| 2024-04-23 | 12.64 |
| 2024-04-22 | 12.83 |
| 2024-04-19 | 12.12 |
| 2024-04-18 | 12.83 |
| 2024-04-17 | 12.96 |
| 2024-04-16 | 13.03 |
| 2024-04-15 | 13.41 |
| 2024-04-12 | 13.61 |
| 2024-04-11 | 14.84 |
| 2024-04-10 | 15.94 |
| 2024-04-09 | 17.30 |
| 2024-04-08 | 17.43 |
| 2024-04-05 | 16.98 |
| 2024-04-04 | 16.91 |
| 2024-04-03 | 17.04 |
| 2024-04-02 | 16.98 |
| 2024-04-01 | 17.56 |
| 2024-03-28 | 18.40 |
| 2024-03-27 | 18.66 |
| 2024-03-26 | 17.76 |
| 2024-03-25 | 17.56 |
| 2024-03-22 | 17.76 |
| 2024-03-21 | 18.60 |
| 2024-03-20 | 19.25 |
| 2024-03-19 | 18.99 |
| 2024-03-18 | 18.53 |
| 2024-03-15 | 21.00 |
| 2024-03-14 | 20.54 |
| 2024-03-13 | 22.29 |
| 2024-03-12 | 22.29 |
| 2024-03-11 | 24.63 |
| 2024-03-08 | 21.77 |
| 2024-03-07 | 122.93 |
| 2024-03-06 | 123.45 |
| 2024-03-05 | 122.15 |
| 2024-03-04 | 124.03 |
| 2024-03-01 | 121.25 |
| 2024-02-29 | 122.15 |
| 2024-02-28 | 126.82 |
| 2024-02-27 | 123.13 |
| 2024-02-26 | 113.79 |
| 2024-02-23 | 114.38 |
